File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0029664507
- PMID: 8609890
- WOS: WOS:A1996UD68900007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: β-adrenoceptor-mediated down-regulation of M2 muscarinic receptors: Role of cyclic adenosine 5′-monophosphate-dependent protein kinase and protein kinase C
Title | β-adrenoceptor-mediated down-regulation of M2 muscarinic receptors: Role of cyclic adenosine 5′-monophosphate-dependent protein kinase and protein kinase C |
---|---|
Authors | |
Issue Date | 1996 |
Publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://www.molpharm.org |
Citation | Molecular Pharmacology, 1996, v. 49 n. 4, p. 629-635 How to Cite? |
Abstract | Stimulation of β2-adrenoceptors with the selective β2 agonist procaterol caused a biphasic decrease in cell surface M2 muscarinic receptor number in human embryonic lung 299 cells when measured with the hydrophilic antagonist [3H]N-methylscopolamine. In contrast, total muscarinic receptor number, measured with the lipophilic antagonist [3H]quinuclidinylbenzilate, decreased after only 24-hr treatments with procaterol. The loss in receptor number at 24 hr was mimicked with the use of forskolin and the cAMP analogue 8-bromo-cAMP, indicating a cAMP-mediated mechanism. Northern blot analysis showed a small and transient increase in m2-receptor mRNA levels up to 2 hr but no long term (24 hr) effect. Chronic (24-hr) treatment with 8-bromo-cAMP also had no effect on m2 muscarinic receptor mRNA, whereas forskolin caused a 50% reduction in the steady state levels of m2 mRNA that could be only partially blocked by the cAMP-dependent protein kinase inhibitor H-8 and the protein kinase C inhibitor GF 109203X. Procaterol-induced down-regulation of M2 receptors was fully blocked by N-[2-(methylamino)ethyl]-5′-isoquinoline-sulfonamide and 2-[1-(3-dimethylaminopropyl)-inol-3-yl]-3-(indol-3-yl)maleimide, implicating both of these kinases in the M2 muscarinic receptor down-regulation. Conversely, the forskolin- and 8-bromo-cAMP-induced down-regulation was only partially inhibited and unaffected by these inhibitors, respectively. In control cells and those treated with procaterol for ≤2 hr, cAMP generation was significantly inhibited by carbachol. The inhibitory effect of carbachol was, however, lost after 24-hr exposure to procaterol. This desensitization was partially reversed by preincubations with H-8 and GF 109203X. Collectively, these results suggest that transregulation of M2 muscarinic receptors by β2-adrenoceptor stimulation can be demonstrated at the protein level in human embryonic lung 299 cells. Furthermore, a role is suggested for cAMP-dependent kinase and PKC in M2 muscarinic receptor down-regulation and their functional desensitization. |
Persistent Identifier | http://hdl.handle.net/10722/162115 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.038 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rousell, J | en_US |
dc.contributor.author | Haddad, EB | en_US |
dc.contributor.author | Mak, JCW | en_US |
dc.contributor.author | Webb, BLJ | en_US |
dc.contributor.author | Giembycz, MA | en_US |
dc.contributor.author | Barnes, PJ | en_US |
dc.date.accessioned | 2012-09-05T05:17:25Z | - |
dc.date.available | 2012-09-05T05:17:25Z | - |
dc.date.issued | 1996 | en_US |
dc.identifier.citation | Molecular Pharmacology, 1996, v. 49 n. 4, p. 629-635 | en_US |
dc.identifier.issn | 0026-895X | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162115 | - |
dc.description.abstract | Stimulation of β2-adrenoceptors with the selective β2 agonist procaterol caused a biphasic decrease in cell surface M2 muscarinic receptor number in human embryonic lung 299 cells when measured with the hydrophilic antagonist [3H]N-methylscopolamine. In contrast, total muscarinic receptor number, measured with the lipophilic antagonist [3H]quinuclidinylbenzilate, decreased after only 24-hr treatments with procaterol. The loss in receptor number at 24 hr was mimicked with the use of forskolin and the cAMP analogue 8-bromo-cAMP, indicating a cAMP-mediated mechanism. Northern blot analysis showed a small and transient increase in m2-receptor mRNA levels up to 2 hr but no long term (24 hr) effect. Chronic (24-hr) treatment with 8-bromo-cAMP also had no effect on m2 muscarinic receptor mRNA, whereas forskolin caused a 50% reduction in the steady state levels of m2 mRNA that could be only partially blocked by the cAMP-dependent protein kinase inhibitor H-8 and the protein kinase C inhibitor GF 109203X. Procaterol-induced down-regulation of M2 receptors was fully blocked by N-[2-(methylamino)ethyl]-5′-isoquinoline-sulfonamide and 2-[1-(3-dimethylaminopropyl)-inol-3-yl]-3-(indol-3-yl)maleimide, implicating both of these kinases in the M2 muscarinic receptor down-regulation. Conversely, the forskolin- and 8-bromo-cAMP-induced down-regulation was only partially inhibited and unaffected by these inhibitors, respectively. In control cells and those treated with procaterol for ≤2 hr, cAMP generation was significantly inhibited by carbachol. The inhibitory effect of carbachol was, however, lost after 24-hr exposure to procaterol. This desensitization was partially reversed by preincubations with H-8 and GF 109203X. Collectively, these results suggest that transregulation of M2 muscarinic receptors by β2-adrenoceptor stimulation can be demonstrated at the protein level in human embryonic lung 299 cells. Furthermore, a role is suggested for cAMP-dependent kinase and PKC in M2 muscarinic receptor down-regulation and their functional desensitization. | en_US |
dc.language | eng | en_US |
dc.publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://www.molpharm.org | en_US |
dc.relation.ispartof | Molecular Pharmacology | en_US |
dc.subject.mesh | Cyclic Amp-Dependent Protein Kinases - Physiology | en_US |
dc.subject.mesh | Down-Regulation | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Protein Kinase C - Physiology | en_US |
dc.subject.mesh | Rna, Messenger - Analysis | en_US |
dc.subject.mesh | Radioligand Assay | en_US |
dc.subject.mesh | Receptors, Adrenergic, Beta-2 - Physiology | en_US |
dc.subject.mesh | Receptors, Muscarinic - Analysis - Genetics | en_US |
dc.title | β-adrenoceptor-mediated down-regulation of M2 muscarinic receptors: Role of cyclic adenosine 5′-monophosphate-dependent protein kinase and protein kinase C | en_US |
dc.type | Article | en_US |
dc.identifier.email | Mak, JCW:judymak@hku.hk | en_US |
dc.identifier.authority | Mak, JCW=rp00352 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 8609890 | - |
dc.identifier.scopus | eid_2-s2.0-0029664507 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0029664507&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 49 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 629 | en_US |
dc.identifier.epage | 635 | en_US |
dc.identifier.isi | WOS:A1996UD68900007 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Rousell, J=6602560061 | en_US |
dc.identifier.scopusauthorid | Haddad, EB=7102803008 | en_US |
dc.identifier.scopusauthorid | Mak, JCW=7103323094 | en_US |
dc.identifier.scopusauthorid | Webb, BLJ=37017893400 | en_US |
dc.identifier.scopusauthorid | Giembycz, MA=7007035171 | en_US |
dc.identifier.scopusauthorid | Barnes, PJ=36064679400 | en_US |
dc.identifier.issnl | 0026-895X | - |